Ebola virus, being highly pathogenic for humans and non-human primates and the subject of former weapons programmes, is now one of the most feared pathogens worldwide. In addition, the lack of pre ...
When the virus returned in 2018, it could be quickly deployed, once the DRC government had approved its experimental use. This vaccine is designed for use against the Zaire strain of Ebola ...
In a new study, the researchers used cryo-electron tomography to examine Ebola virus’s molecular structure to uncover targets for broadly effective antivirals. This work is published in Cell ...
If Ebola virus was in his body ... chip the size of a caraway seed for later identification, and most important, drawing blood from a vein in the animal’s tiny arm. One well-aimed poke with ...
In 2017, China’s food and drug authority approved its first Ebola virus vaccine, making China only the second country to licence a vaccine for this deadly disease. Causing a sudden onset of high ...
2022 — A new tool can quickly and reliably identify the presence of Ebola virus in blood samples, according to a new study. The technology, which uses so-called optical microring resonators ...
More than 40 years after it was identified, the Ebola virus continues to defy drugs, treatment plans—and experts’ best efforts to solve its mysteries. 1. The vaccine’s requirements Ebola ...
In a new Cell study, scientists in LJI's Center for Vaccine Innovation share the first detailed, complete images of a viral structure called the Ebola virus nucleocapsid. This breakthrough may ...
Targeting Ebola virus -- and more As Watanabe explains, targeting the nucleocapsid spells game over for the virus. "If you don't have a nucleocapsid, nothing can happen.